[1] Cohen M H,Johnson J R,Chen Y F,et al. FDA drug approval summary:erlotinib(Tarceva)tablets [J] . Oncologist,2005,10(7):461- 466. [2] Takeda K, Hida T, Sato T, et al. Randomized phase III trial of platinum-doublet chemotherapy followed by gefitinib compared with continued platinum-doublet chemotherapy in Japanese patients with advanced non-small-cell lung cancer: results of a west Japan thoracic oncology group trial (WJTOG0203)[J].J Clin Oncol,2010,28(5):753-760. [3] 张磊,马韬,叶正宝,等. 厄洛替尼致间质性肺炎一例[J]. 外科理论与实践,2008,13(3):279-280. [4] 管茶香,孙秀泓,罗自强,等. 表皮生长因子对肺泡巨噬细胞趋化性的调控[J].中国应用生理学杂志,1998,14(1):43- 45. [5] 杨庆羚,刘翩,王斌,等.EGFR-TKIs 治疗晚期非小细胞肺癌并发间质性肺炎4 例报告并文献复习[J].第三军医大学学报,2012,32(20):2060-2062. [6] 雷莉,罗继征,孟军英,等.厄洛替尼引起急性间质性肺病死亡2例[J].药物不良反应杂志,2007,9(4):277-278. |